Literature DB >> 108727

Tryptophan antidepressant 'physiological sedative': fact or fancy?

A J Cooper.   

Abstract

Some recent publications relating to the allegedly antidepressive and sedative effects of L-tryptophan the precursor of 5-HT have been reviewed. The evidence to date suggests that the amino acid is as effective as standard tricyclic drugs in alleviating the symptoms of depression, especially those cases presenting with mainly psychomotor retardation, and is synergistic with MAOIs. L-Tryptophan would also appear to be a 'physiological sedative'. This action, however, appears to be related to the time of administration and at present has only been demonstrated at night. when endogenous levels of 5-HT are at their peak. In terms of practical therapeutics L-tryptophan would appear to have greater potential as an 'antidepressant' than as a 'sedative'.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 108727     DOI: 10.1007/bf00426818

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

1.  A comparative study of selected antidepressant medications and EST.

Authors:  M GREENBLATT; G H GROSSER; H WECHSLER
Journal:  Am J Psychiatry       Date:  1962-08       Impact factor: 18.112

2.  The work of a psychosurgical unit.

Authors:  P K Bridges; J R Bartlett
Journal:  Postgrad Med J       Date:  1973-12       Impact factor: 2.401

3.  Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis.

Authors:  A Tagliamonte; P Tagliamonte; J Perez-Cruet; G L Gessa
Journal:  Nat New Biol       Date:  1971-01-27

4.  Antidepressant action of tryptophan.

Authors:  S N Young; T L Sourkes
Journal:  Lancet       Date:  1974-10-12       Impact factor: 79.321

5.  The efficacy of antidepressant drugs. A review of research (1958-1972).

Authors:  J B Morris; A T Beck
Journal:  Arch Gen Psychiatry       Date:  1974-05

6.  Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness.

Authors:  R M Post; J Kotin; F K Goodwin; E K Gordon
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

7.  Tryptophan and an MAOI (nialamide) in the treatment of depression. A double-blind study.

Authors:  J L Ayuso Gutierrez; J J Aliño
Journal:  Int Pharmacopsychiatry       Date:  1971

8.  Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan.

Authors:  S E Moller; L Kirk; K H Fremming
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

9.  Letter: Potentiation of antidepressant action of clomipramine by tryptophan.

Authors:  J Walinder; A Skott; A Nagy; A Carlsson; B E Roos
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

10.  The acute effects of oral (--)-tryptophan in human subjects.

Authors:  M H Greenwood; M H Lader; B D Kantameneni; G Curzon
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

View more
  3 in total

1.  Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

Authors:  R D Levitan; J H Shen; R Jindal; H S Driver; S H Kennedy; C M Shapiro
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Evaluation of L-tryptophan for treatment of insomnia: a review.

Authors:  D Schneider-Helmert; C L Spinweber
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  L-Tryptophan: Biochemical, nutritional and pharmacological aspects.

Authors:  E L Sainio; K Pulkki; S N Young
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.